Idaho Code
Chapter 1 - IDAHO FOOD, DRUG AND COSMETIC ACT
Section 37-127 - DRUGS OR DEVICES DEEMED MISBRANDED.

37-127. DRUGS OR DEVICES DEEMED MISBRANDED. A drug or device shall be deemed to be misbranded–(a) If its labeling is false or misleading in any particular.
(b) If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count; Provided, that under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the board.
(c) If any word, statement, or other information required by or under authority of this act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
(d) If it is for use by man and contains any quantity of the narcotic or hypnotic substance alpha-eucaine, barbituric acid, beta-eucaine, bromal, cannabis, carbromal, chloral, coca, cocaine, codeine, heroin, marihuana [marijuana], morphine, opium, paraldehyde, peyete [peyote], or sulphonmethane, or any chemical derivative of such substance, which derivative has been by the board after investigation, found to be, and by regulations under this act, designated as habit forming, unless its label bears the name and quantity or proportion of such substance or derivative and in juxtaposition therewith the statement "Warning–May be habit forming."
(e) If it is a drug and is not designated solely by a name recognized in an official compendium unless its label bears (1) the common or usual name of the drug, if such there be; and (2), in case it is fabricated from two (2) or more ingredients, the common or usual name of each active ingredient, including the kind and quantity or proportion of any alcohol, and also including, whether active or not, the name and quantity or proportion of any bromides, ether, chloroform, acetanilid, acotphenetidin, amidapyrine, anti-pyrine, atropine, hyoscine, hyoscyamine, arsenic, digitalis glucosines, mercury, ouabain, strophanthin, strychnine, thyroid, or any derivative or preparation of any substances, contained therein: Provided, that to the extent that compliance with the requirements of clause (2) of this paragraph is impracticable, exemptions shall be established by regulations promulgated by the board.
(f) Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: Provided, that where any requirement of clause (1) of this paragraph, as applied to any drug or device, is not necessary for the protection of the public health, the board shall promulgate regulations exempting such drug or device from such requirements.
(g) If it purports to be a drug the name of which is recognized in an official compendium, unless it is packaged and labeled as prescribed therein: Provided, that the method of packing may be modified with the consent of the board. Whenever a drug is recognized in both the United States Pharmacopoeia and the Homeopathic Pharmacopoeia of the United States, it shall be subject to the requirements of the United States Pharmacopoeia with respect to packaging and labeling unless it is labeled and offered for sale as a homeopathic drug, in which case it shall be subject to the provisions of the Homeopathic Pharmacopoeia of the United States, and not to those of the United States Pharmacopoeia.
(h) If it has been found by the board to be a drug liable to deterioration, unless it is packaged in such form and manner, and its label bears a statement of such precautions, as the board shall by regulations require as necessary for the protection of public health. No such regulation shall be established for any drug recognized in an official compendium until the board shall have informed the appropriate body charged with the revision of such compendium of the need for such packaging or labeling requirements and such body shall have failed within a reasonable time to prescribe such requirements.
(i) (1) If it is a drug and its container is so made, formed, or filled as to be misleading; or (2) if it is an imitation of another drug; or (3) if it is offered for sale under the name of another drug.
(j) If it is dangerous to health when used in the dosage, or with the frequency or duration prescribed, recommended, or suggested in the labeling thereof.
(k) If it is a drug sold at retail and quantity of aminopyrine, barbituric acid, cinchophen, dinitrophenol, sulfanilamide or their derivatives, or any other drug which has been found by the board to be dangerous to health when used in the dosage, or with the frequency or duration prescribed, recommended, or suggested in the labeling thereof, and so designated by the board in a regulation adopted; unless it is sold on a written prescription signed by a member of the medical, osteopathic, chiropodial, dental, or veterinary profession who is licensed by law to administer such drug, and its label bears the name and place of business of the seller, the serial number and date of such prescription, and the name of such member of the medical, osteopathic, chiropodial, dental, or veterinary profession.
(l) A drug sold on a written prescription signed by a member of the medical, osteopathic, chiropodial, dental, or veterinary profession (except a drug sold in the course of the conduct of a business of selling drugs pursuant to diagnosis by mail) shall be exempt from the requirements of this section if–(1) such member of the medical, osteopathic, chiropodial, dental, or veterinary profession is licensed by law to administer such drug, and (2) such drug bears a label containing the name and place of business of the seller, the serial number and date of such prescription, and the name of such member of the medical, osteopathic, chiropodial, dental, or veterinary profession.

History:
[37-127, added 1959, ch. 153, sec. 15, p. 351.]

Structure Idaho Code

Idaho Code

Title 37 - FOOD, DRUGS, AND OIL

Chapter 1 - IDAHO FOOD, DRUG AND COSMETIC ACT

Section 37-113 - SHORT TITLE.

Section 37-114 - DEFINITIONS.

Section 37-115 - PROHIBITED ACTS.

Section 37-116 - INJUNCTIONS AUTHORIZED.

Section 37-117 - VIOLATIONS — PENALTY — EXCEPTIONS.

Section 37-117A - REPORTING AND DISCLOSURE REQUIREMENTS FOR EMPLOYMENT RELATED ADULTERATION OR MISAPPROPRIATION OF CERTAIN DRUGS.

Section 37-118 - TAGGING AND DETENTION OF ARTICLE OR PRODUCT SUSPECTED OF BEING ADULTERATED OR MISBRANDED — EMBARGO AND CONDEMNATION UNDER CERTAIN CONDITIONS AND BY CERTAIN PROCEDURES.

Section 37-119 - PROSECUTIONS OF VIOLATIONS — RIGHT OF PARTY TO NOTICE AND PRESENTATION OF VIEWS PRIOR TO PROSECUTION.

Section 37-120 - REPORT OF MINOR VIOLATIONS.

Section 37-121 - PROMULGATION OF REASONABLE STANDARDS BY BOARD.

Section 37-122 - FOOD DEEMED ADULTERATED.

Section 37-123 - FOOD DEEMED MISBRANDED.

Section 37-124 - CONTAMINATION OF FOOD WITH MICROORGANISMS — PERMIT REGULATIONS — ACCESS TO FACTORY.

Section 37-125 - POISONOUS OR DELETERIOUS SUBSTANCE — REGULATIONS AS TO USE.

Section 37-126 - DRUGS OR DEVICES DEEMED ADULTERATED.

Section 37-127 - DRUGS OR DEVICES DEEMED MISBRANDED.

Section 37-128 - SALE OF NEW DRUGS — REGULATIONS AND PROCEDURES.

Section 37-129 - COSMETICS DEEMED ADULTERATED.

Section 37-130 - COSMETICS DEEMED MISBRANDED.

Section 37-131 - FALSE ADVERTISING.

Section 37-132 - REGULATIONS BY BOARD — HEARINGS — NOTICE.

Section 37-133 - INSPECTION OF ESTABLISHMENTS — EXAMINATION OF SPECIMENS — REPORTS — RECEIPT FOR SAMPLES.

Section 37-134 - PUBLICATION OF REPORTS BY DIRECTOR — DISSEMINATION OF INFORMATION.